Files
2026-07-06 17:27:20 -04:00

5.2 KiB

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill AN ACT relating to controlled substance monitoring. Amend KRS 218A.202 to require certain hospitals to report positive toxicology screens to the Cabinet for Health and Family Services; permit federal prosecutors and agents to use KASPER; permit practitioners or pharmacists to review KASPER reports of birth mothers of potentially drug-exposed infants; remove a pilot program relating to real-time electronic monitoring; make other technical corrections; amend KRS 218A.240 to conform. AN ACT relating to controlled substance monitoring. Amend KRS 218A.202 to require certain hospitals to report positive toxicology screens to the Cabinet for Health and Family Services; permit federal prosecutors and agents to use KASPER; permit practitioners or pharmacists to review KASPER reports of birth mothers of potentially drug-exposed infants; remove a pilot program relating to real-time electronic monitoring; make other technical corrections; amend KRS 218A.240 to conform. us/states/ky Kentucky General Assembly 2017RS HB 314 Kentucky HB 314 (2017RS)
bill
enacted
6 25 0 2017-02-10 2017-03-27 openstates ocd-bill/b90c74fa-dda1-4101-998d-0e5025e5d6e1 http://www.lrc.ky.gov/record/17RS/HB314.htm 6de5fb5b0b0803794ba0b51ad50e6d8fcd5e218c8d6ba71c7a96fe535fe5f451 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-ky

Kentucky HB 314 (2017RS) — AN ACT relating to controlled substance monitoring. Amend KRS 218A.202 to require certain hospitals to report positive toxicology screens to the Cabinet for Health and Family Services; permit federal prosecutors and agents to use KASPER; permit practitioners or pharmacists to review KASPER reports of birth mothers of potentially drug-exposed infants; remove a pilot program relating to real-time electronic monitoring; make other technical corrections; amend KRS 218A.240 to conform.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. HB 314 (As Introduced) (committee substitute) — source
  2. HCS1 (committee substitute) — source
  3. Most Recent Version (committee substitute) — source
  4. SCA1 (committee substitute) — source
  5. SCS1 (committee substitute) — source
  6. SFA1 (committee substitute) — source

Timeline

The legislative action history — every referral, reading, and vote.

  • 2017-02-10 Introduced in House introduction
  • 2017-02-14 To Health and Family Services (H) referral-committee
  • 2017-02-22 Posted in committee
  • 2017-02-23 Reported favorably, 1st reading, to Calendar with Committee Substitute reading-1
  • 2017-02-24 2nd reading, to Rules reading-2
  • 2017-02-24 Posted for passage in the Regular Orders of the Day for Monday, February 27, 2017
  • 2017-02-27 3rd reading, passed 88-0 with Committee Substitute reading-3, passage
  • 2017-02-28 Received in Senate
  • 2017-02-28 To Health & Welfare (S) referral-committee
  • 2017-03-07 Taken from Health & Welfare (S)
  • 2017-03-07 1st reading reading-1
  • 2017-03-07 Returned to Health & Welfare (S)
  • 2017-03-08 Reported favorably, 2nd reading, to Rules with Committee Substitutes and committee amendment (1-title) reading-2
  • 2017-03-08 Floor amendment (1) filed to Committee Substitute amendment-introduction
  • 2017-03-14 Posted for passage in the Regular Orders of the Day for Tuesday, March 14, 2017
  • 2017-03-14 3rd reading, passed 33-3 with Committee Substitute, committee amendment (1-title) and floor amendment (1) reading-3, passage
  • 2017-03-14 Received in House
  • 2017-03-14 To Rules (H) referral-committee
  • 2017-03-14 Posted for passage for concurrence in Senate Committee Substitute, committee amendment (1-title) and floor amendment (1) on Wednesday, March 15, 2017
  • 2017-03-15 House concurred in Senate Committee Substitute, floor amendment (1) and committee amendment (1-title)
  • 2017-03-15 Bill passed 85-9
  • 2017-03-15 Enrolled, signed by Speaker of the House
  • 2017-03-15 Enrolled, signed by President of the Senate
  • 2017-03-15 Delivered to Governor
  • 2017-03-27 Signed by Governor (Acts, ch. 138) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/b90c74fa-dda1-4101-998d-0e5025e5d6e1. Confidence: reported (aggregated from official Kentucky legislature records).